Cambridge, Massachusetts-based Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for treating ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Domestic ...

Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow morning. Here’s what to look for. Biogen beat analysts’ revenue expectations by 1.2% last quarter, reporting ...

Members of Congress have traded $BIIB stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales. Here’s a breakdown of recent ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the September 2025 expiration. One of the key data points that goes into the price an option buyer is willing to ...

I rate BIIB stock a hold due to current uncertainties; will reconsider upon sustained revenue growth, regulatory approvals, or positive trial data. Despite representing great value from an ...

In its place, though, Griffin was buying Biogen (NASDAQ:BIIB) hand over fist, acquiring more than 372,000 shares of the biotech at a cost of $72 million. It was a completely new position for the ...

Biogen Inc. closed 47.73% short of its 52-week high of $238.00, which the company reached on July 12th.